当前位置：首页 > 文献互助 > 互助详情

CD3 bispecific antibody–induced cytokine release is dispensable for cytotoxic T cell activity复制

用户RcsoTKlzyIwM 10小时前 8 20 求助中 帖子自动结束时间: 2025-06-20 19:18:03

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: DOI: 10.1126/scitranslmed.aax8861复制

文献链接: https://www.science.org/doi/10.1126/scitranslmed.aax8861复制

其他信息:

出版社: American Association for the Advancement of Science (AAAS)
作者: Ji Li; Robert Piskol; Ryan Ybarra; Ying-Jiun J. Chen; Jason Li; Dionysos Slaga; Maria Hristopoulos; Robyn Clark; Zora Modrusan; Klara Totpal; Melissa R. Junttila; Teemu T. Junttila

上一篇：Inavolisib plus letrozole or fulvestrant in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer (GO39374): An open-label, multicentre, dose-escalation and dose-expansion phase 1/1b study

下一篇：An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors

互助时间线

2025-06-15 19:18:03 [发起求助]

最新发布的求助

A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis 5小时前
An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors 10小时前
CD3 bispecific antibody–induced cytokine release is dispensable for cytotoxic T cell activity 10小时前
Inavolisib plus letrozole or fulvestrant in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer (GO39374): An open-label, multicentre, dose-escalation and dose-expansion phase 1/1b study 13小时前
Decade trends in risk factors, treatments, and prognosis of minor ischemic stroke and tia in china 14小时前
Encapsulation of Adipose-Derived Stem Cells in Collagen-Based Hydrogel 14小时前
Inavolisib plus letrozole or fulvestrant in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer (GO39374): An open-label, multicentre, dose-escalation and dose-expansion phase 1/1b study 15小时前
Discovery of pyrrolo[2,3-d]pyrimidine derivatives as novel FLT3/IRAK4 inhibitors 17小时前
Knowledge, Attitudes, and Practices Regarding Meningococcal B Vaccination Since the 2015 Recommendation: A Review 18小时前
Targeting both wild-type EGFR and its drug-resistant mutants with erlotinib-aptamer conjugates 18小时前
Discovery and optimization of novel tetrahydrothiazolopyridine-based pyrimidines as highly potent cyclin-dependent kinase 9 (CDK9) inhibitors 18小时前
Discovery of pyrrolo[2,3-d]pyrimidine derivatives as novel FLT3/IRAK4 inhibitors 18小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com